About EARLI INC.
Earli Inc. is a biotechnology company leveraging AI to develop genetic switches that program cancer cells to self-destruct, with a focus on early cancer detection and treatment. The company has received recognition from notable institutions and media outlets for its innovative approach.
AI-driven development of genetic switchesEarly cancer detection using synthetic biomarkersDNA nanoplasmids as diagnostic toolsCollaboration with Accenture on cancer detection initiatives
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EARLI INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.